Evaluation of the rheumatoid factors of the IgG, IgM and IgA isotypes as prognostic parameters for rheumatoid arthritis among Iraqi patients

Indian Journal of Pathology and Microbiology

Volumn 53, Issue 3, 2010, Pages 439-444

  Ahmed, Mohanad M ^a   Obaid Al Ruhaimi, Khalid A ^a   Mohammed, Suhad Hadi ^a  

^a UNIVERSITY OF KERBALA   (Iraq)

Author keywords

Erosive rheumatoid arthritis; IgA RF; IgG RF; IgM RF; Rheumatoid arthritis; Rheumatoid Factors

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RHEUMATOID FACTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMAGE ANALYSIS; IMMUNODETECTION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL PARAMETERS; IRAQ; MAJOR CLINICAL STUDY; MALE; MEDICAL EXPERT; OUTCOME ASSESSMENT; PROGNOSIS; RADIOLOGIST; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SERUM; TITRIMETRY; X RAY FILM; ARTHROGRAPHY; BLOOD; IMMUNOLOGY; JOINT; MIDDLE AGED; PATHOLOGY;

ADULT; ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IRAQ; JOINTS; MALE; MIDDLE AGED; PROGNOSIS; RHEUMATOID FACTOR;

EID: 77955883404     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.68265     Document Type: Article

References (30)

1. Firestein GS. Etiology and pathogenesis of rheumatoid arthritis. In: Harris ED, Budd RC, Genovese MC, Firestein GS, Sargent JS, Sledge CB, editors. Kelley's Textbook of Rheumatology. 7th ed. Philadelphia, Pa: Saunders Elsevier; 2005.
2. Weyand CM, Kang YM, Kurtin PJ, Goronzy JJ. The power of the third dimension: tissue architecture and autoimmunity in rheumatoid arthritis. Curr Opin Rheumatol 2003;15:259-266
3. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatology association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31: 315-324
4. Knijff-Dutmer E, Drossaers-Bakker W, Verhoeven A, van der Sluijs Veer G, Boers M, van der Linden S, et al. Rheumatoid factor measured by fluoroimmunoassay: A responsive measure of rheumatoid arthritis disease activity that is associated with joint damage. Ann Rheum Dis 2002;61:603-607
5. van Leeuwen MA, Westra J, van Riel PL, Limburg PC, van Rijswijk MH. IgM, IgA and IgG rheumatoid factors in early rheumatoid arthritis predictive of radiological progression?. Scand Scand J Rheumatol 1995;24:146-153
6. van Zeben D, Hazes JM, Zwinderman AH, Cats A, van der Voort EA, Breedveld FC. Clinical significance of rheumatoid factors in early rheumatoid arthritis: Results of a follow up study. Ann Rheum Dis 1992;51:1029-1035
7. Skogh T, Kastbom A, Sjwall C. The B cells are back. Drug Discov Today Dis Mech 2005;2:351-357
8. Hulett MD, Hogarth PM. Molecular basis of Fc receptor function. Adv Immunol 1994;57:1-127.
9. Bolland S, Ravetch JV. Spontaneous autoimmune disease in Fc (gamma) RIIB-deficient mice results from strain -specific epistasis. Immunity 2000;13:277-285
10. Ravetch JV. Fc receptors. Curr Opin Immunol 1997;9:121-125
11. Clynes R, Maizes JS, Guinamard R, Ono M, Takai T, Ravetch JV. Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J Exp Med 1999;189:179-185
12. Kleinau S, Martinsson P, Heyman B. Induction and suppression of collagen-induced arthritis is dependent on distinct Fc gamma receptors. J Exp Med 2000;191:1611-1616
13. Van den Berg WB. Lessons from animal models of arthritis. Curr Rheumatol Rep 2002;4:232-239
14. Abrahams VM, Cambridge G, Lydyard PM, Edwards JC. Induction of tumor necrosis factor alpha production by adhered human monocytes: A key role for Fc gamma receptor type IIIa in rheumatoid arthritis. Arthritis Rheum 2000;43:608-616
15. Blom AB, Radstake TR, Holthuysen AE, Slöetjes AW, Pesman GJ, Sweep FG, et al. Increased expression of Fc gamma receptors II and III on macrophage of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase. Arthritis Rheum 2003;48:1002-1014
16. Wijngaarden S, van Roon JA, Bijlsma JW, van de Winkel JG, Lafeber FP. Fcgamma receptor expression levels on monocytes are elevated in rheumatoid arthritis pateints with high erythrocyte sedementation rate who do not use anti-rheumatic drugs. Rheumatology (Oxford) 2003;42:681-688
17. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twentyeight- joint counts: Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
18. Fransen J, Creemers MC, Van Riel PL. Remission in rheumatoid arthritis: Agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology (Oxford) 2004;43:1252-1255
19. van Gestel AM, Prevoo ML, van 't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Development and validation of the European league against rheumatsim response criteria for rehumatoid arthiritis. Arthritis Rheum 1996;39:34-40.
20. Hulsmans HM, Jacobs JW, van der Heijde DM, van Albada-Kuipers GA, Schenk Y, Bijlsma JW. The course of radiological damage during the first six years of rheumatoid arthritis. Arthritis Rheum 2000;43:1927-1940
21. Sharp JT, Wolfe F, Mitchell DM, Bloch DA. The progression of erosion and joint space narrowing scores in rheumatoid arthritis during the first twenty-five years of disease. Arthritis Rheum 1991;34:660-668
22. Wolfe F, Sharp JT. Radiographic outcome of recent-onset rheumatoid arthritis: a 19-year study of radiographic progression. Arthritis Rheum 1998;41:1571-1582
23. Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-1602
24. Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, et al. Two-year, blinded, randomized controlled trial of treatment of active rheumatoid arthritis with leflunamide compared to methotrxate. Utilization of Leflunamide in the Treatment of Rheumatoid Arthritis trial Investigator Group. Arthritis Rheum 2001;44:1984-1992
25. Winska Wiloch H, Thompson K, Young A, Corbett M, Shipley M, Hay F. IgA and IgM rheumatoid factors as markers for later erosive changes in rheumatoid arthritis(RA). Scand J Rheumatol Suppl 1988;75:238-243
26. Gordon DA, Stein JL, Broder I. The extra-articular features of rheumatoid arthritis. A systematic analysis of 127cases. Am J Med 1973;54:445-452
27. Turesson C, Jacobsson L, Bergström U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford) 1999;38: 668-674 (Pubitemid 29507338)
28. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002;29:62-67
29. Gabriel SE, Crowson CS, Kremers HM, Doran MF, Turesson C, O'Fallon WM, et al. Survival in rheumatoid arthritis: a population- based analysis of trends over 40 years. Arthritis Rheum 2003;48:54-58
30. Päi S, Päi L, Birkenfeldt R. Correlation of serum IgA rheumatoid factor levels with disease severity in rheumatoid arthritis. Scand J Rheumatol 1998;27:252-256